{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:41:53Z","timestamp":1792543313827,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.mehy.2011.09.009","type":"journal-article","created":{"date-parts":[[2011,10,2]],"date-time":"2011-10-02T21:13:25Z","timestamp":1317590005000},"page":"1088-1093","source":"Crossref","is-referenced-by-count":106,"title":["Hypothesis: Hyperhomocysteinemia is an indicator of oxidant stress"],"prefix":"10.1016","volume":"77","author":[{"given":"Maureane","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2011.09.009_b0005","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2011.09.009_b0010","first-page":"566","article-title":"Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism","volume":"80","author":"Eichinger","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mehy.2011.09.009_b0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2011.09.009_b0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00062752-199809000-00007","article-title":"Mechanisms of thrombosis in hyperhomocysteinemia","volume":"5","author":"Lentz","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.mehy.2011.09.009_b0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2011.09.009_b0030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.293.9.1082","article-title":"Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial","volume":"293","author":"Sato","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2011.09.009_b0035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/aje\/kwi259","article-title":"Homocysteine and cognitive performance in the Framingham offspring study: age is important","volume":"162","author":"Elias","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2011.09.009_b0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0045","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.2337\/diacare.28.11.2750","article-title":"Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study","volume":"28","author":"Cho","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2011.09.009_b0050","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00125-003-1104-x","article-title":"Homocysteine as a risk factor for nephropathy and retinopathy in type 2 diabetes","volume":"46","author":"Looker","year":"2003","journal-title":"Diabetologia"},{"issue":"Suppl. 2","key":"10.1016\/j.mehy.2011.09.009_b0055","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/PL00014300","article-title":"The metabolism of homocysteine: pathways and regulation","volume":"157","author":"Finkelstein","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.mehy.2011.09.009_b0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ajcn\/57.1.47","article-title":"Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia","volume":"57","author":"Ubbink","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2011.09.009_b0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(96)05809-1","article-title":"Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients","volume":"123","author":"Bostom","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2011.09.009_b0070","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0075","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI112442","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2011.09.009_b0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(95)05730-7","article-title":"Homocysteine mediated endothelial cell toxicity and its amelioration","volume":"122","author":"Blundell","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2011.09.009_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jn\/131.1.33","article-title":"Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers","volume":"131","author":"Huang","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2011.09.009_b0090","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0753-3322(01)00095-6","article-title":"Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells","volume":"55","author":"Chern","year":"2001","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.mehy.2011.09.009_b0095","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jcb.20837","article-title":"Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia","volume":"98","author":"Tyagi","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.mehy.2011.09.009_b0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.0000087642.01082.E4","article-title":"Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes","volume":"93","author":"Zeng","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2011.09.009_b0105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1749-6632.2002.tb04698.x","article-title":"Reactive oxygen species accumulation induced by homocysteine in human platelets","volume":"973","author":"Signorello","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mehy.2011.09.009_b0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI118776","article-title":"The oxidant stress of hyperhomocyst(e)inemia","volume":"98","author":"Loscalzo","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2011.09.009_b0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0891-5849(93)90151-J","article-title":"Homocysteine metabolism and the oxidative modification of proteins and lipids","volume":"14","author":"Olszewski","year":"1993","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0120","doi-asserted-by":"crossref","unstructured":"Welch GN, Upchurch Jr GR, Loscalzo J. Homocysteine, oxidative stress, and vascular disease. Hosp Pract (Off Ed) 1997;32:81\u20132, 5, 8\u201392.","DOI":"10.1080\/21548331.1997.11443510"},{"key":"10.1016\/j.mehy.2011.09.009_b0125","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1089\/ars.2007.1806","article-title":"Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals","volume":"9","author":"Dayal","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mehy.2011.09.009_b0130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/oxfordjournals.aje.a008798","article-title":"Lowered risks of hypertension and cerebrovascular disease after vitamin\/mineral supplementation: the Linxian Nutrition Intervention Trial","volume":"143","author":"Mark","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2011.09.009_b0135","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.299.17.2086","article-title":"Homocysteine-lowering B vitamin therapy in cardiovascular prevention \u2013 wrong again?","volume":"299","author":"Lonn","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2011.09.009_b0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2011.09.009_b0145","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2337\/db09-0087","article-title":"Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial","volume":"58","author":"Song","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2011.09.009_b0150","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","article-title":"Cardiovascular morbidity and mortality in the atherosclerosis and folic acid supplementation trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial","volume":"47","author":"Zoungas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2011.09.009_b0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","article-title":"Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease","volume":"15","author":"Wrone","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2011.09.009_b0160","doi-asserted-by":"crossref","first-page":"751S","DOI":"10.1093\/jn\/126.suppl_3.751S","article-title":"More folic acid for everyone, now","volume":"126","author":"Oakley","year":"1996","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2011.09.009_b0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-135-2-200107170-00014","article-title":"Power shortage: clinical trials testing the \u201chomocysteine hypothesis\u201d against a background of folic acid-fortified cereal grain flour","volume":"135","author":"Bostom","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0170","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1042\/bst0311059","article-title":"Oxidant stress: a key determinant of atherothrombosis","volume":"31","author":"Loscalzo","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.mehy.2011.09.009_b0175","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/o70-156","article-title":"Oxidative degradation of dihydrofolate and tetrahydrofolate","volume":"48","author":"Chippel","year":"1970","journal-title":"Can J Biochem"},{"key":"10.1016\/j.mehy.2011.09.009_b0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0003-2697(78)90511-0","article-title":"The oxidative cleavage of folates. A critical study","volume":"84","author":"Maruyama","year":"1978","journal-title":"Anal Biochem"},{"key":"10.1016\/j.mehy.2011.09.009_b0185","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0891-5849(01)00543-3","article-title":"Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity","volume":"30","author":"Joshi","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0190","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1515\/CCLM.2001.113","article-title":"Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?","volume":"39","author":"Fuchs","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.33549\/physiolres.930520","article-title":"The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia","volume":"54","author":"Racek","year":"2005","journal-title":"Physiol Res"},{"key":"10.1016\/j.mehy.2011.09.009_b0200","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2119\/molmed.2010.00008","article-title":"Early increase of plasma homocysteine in sepsis patients with poor outcome","volume":"16","author":"Ploder","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0205","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1515\/CCLM.2003.221","article-title":"Hyperhomocysteinemia and immune activation","volume":"41","author":"Schroecksnadel","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.mehy.2011.09.009_b0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thromres.2006.08.001","article-title":"Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia","volume":"120","author":"Sauls","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.mehy.2011.09.009_b0215","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1538-7836.2003.00053.x","article-title":"Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia","volume":"1","author":"Sauls","year":"2003","journal-title":"J Thromb Haemost"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711004622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711004622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:45:23Z","timestamp":1741772723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711004622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0306987711004622"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.09.009","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}